MAPK uncouples cell cycle progression from cell spreading and cytoskeletal organization in cycling cells by Coert Margadant et al.
RESEARCH ARTICLE
MAPK uncouples cell cycle progression from cell spreading
and cytoskeletal organization in cycling cells
Coert Margadant • Lobke Cremers •
Arnoud Sonnenberg • Johannes Boonstra
Received: 30 November 2011 / Revised: 19 July 2012 / Accepted: 23 July 2012 / Published online: 25 August 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract Integrin-mediated cytoskeletal tension supports
growth-factor-induced proliferation, and disruption of the
actin cytoskeleton in growth factor-stimulated cells pre-
vents the re-expression of cyclin D and cell cycle re-entry
from quiescence. In contrast to cells that enter the cell cycle
from G0, cycling cells continuously express cyclin D, and
are subject to major cell shape changes during the cell cycle.
Here, we investigated the cell cycle requirements for
cytoskeletal tension and cell spreading in cycling mam-
malian cells that enter G1-phase from mitosis. Disruption of
the actin cytoskeleton at progressive time-points in G1-
phase induced cell rounding, FA disassembly, and attenu-
ated both integrin signaling and growth factor-induced p44/
p42 mitogen-activated protein kinase activation. Although
cyclin D expression was reduced, the expression of cyclin
A and entry into S-phase were not affected. Moreover,
expression of cyclin B1, progression through G2- and
M-phase, and commitment to a new cell cycle occurred
normally. In contrast, cell cycle progression was strongly
prevented by inhibition of MAPK activity in G1-phase,
whereas cell spreading, cytoskeletal organization, and
integrin signaling were not impaired. MAPK inhibition also
prevented cytoskeleton-independent cell cycle progression.
Thus, these results uncouple the requirements for cell
spreading and cytoskeletal organization from MAPK sig-
naling, and show that cycling mammalian cells can
proliferate independently of actin stress fibers, focal adhe-
sions, or cell spreading, as long as a threshold level of
MAPK activity is sustained.
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Introduction
Cell cycle progression in normal mammalian cells requires
both growth factor stimulation and cell adhesion to the
extracellular matrix (ECM) mediated by transmembrane
heterodimeric ab receptors called integrins [1, 2]. Engage-
ment of virtually all integrins leads to the assembly of large
macromolecular complexes called focal adhesions (FAs), at
least in cells in culture, where they connect to actin stress
fibers. In this way, integrins generate intracellular tension,
mediate cell spreading over the substrate, and initiate several
signaling pathways [3, 4]. Disruption of stress fibers with
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pharmacological agents prevents integrin-mediated cell
spreading, and inhibits growth-factor-induced re-entry into
G1-phase from quiescence [5–14]. Cell cycle arrest upon
cytoskeletal disruption is characterized by a failure to
downregulate the cell cycle inhibitor p27KIP1, to induce
sustained p44/p42 mitogen-activated protein kinase (MAPK)
phosphorylation and activation, and to induce expression of
D-type cyclins, which together with cdk4/6 are essential
factors for promoting G1/S-phase progression [12–15]. The
same is observed upon loss of adhesion, or restriction of cell
spreading on micro-patterned surfaces [16–18].
Induction of cyclin D expression is crucial for growth
factor-stimulated re-entry into G1-phase from quiescence,
and is the main step that is sensitive to cytoskeletal tension
[5, 6, 19–22]. Overexpression of cyclin D1 can rescue
proliferation in non-adherent cells, and is often associated
with the anchorage-independent growth of tumor cells [23–
26]. It thus seems that the requirement of cell spreading for
proliferation is not absolute, and that cell cycle progression
and cell spreading can be disconnected as long as cyclin D1
is expressed. Indeed, normal G0- to S-phase progression in
fibroblasts depends on integrin-sustained Rho activation,
stress fiber formation and cell spreading, which leads to
mid-G1-phase induction of cyclin D expression [27, 28].
However, upon inhibition of Rho signaling, a Rac/Cdc42-
driven pathway induces early expression of cyclin D and
shortening of G1 phase, and allows for cell cycle progres-
sion in the absence of stress fibers or cell spreading [28].
Hence, depending on the circumstances, cells may switch
between a tension-dependent and -independent mode
of proliferation, provided that there is a signal to induce
cyclin D.
Consistent with such a model, we have previously shown
that in cycling cells (i.e., as opposed to cells entering G1-
phase from quiescence), which express cyclin D and contain
low levels of cell cycle inhibitors, prevention of post-
mitotic stress fiber assembly and concomitant cell spreading
does not inhibit progression through G1-phase [29]. We
hypothesize that after cytokinesis, cells can commit to a
new cycle either in a high-tensional state with extensive
stress fibers and FAs, or rounded without extensive stress
fibers and FAs, depending on the environmental require-
ments and/or restraints. Possibly, cell spreading elicits an
irreversible cell-cycle program so that artificial cell
rounding will inhibit cell cycle progression, which would
explain why quiescent, spread cells do not enter the cell
cycle upon cytoskeletal disruption. In addition, M-to-S-
phase progression may only require cytoskeletal integrity
and cell spreading during a discrete time-window, as has
been observed for capillary endothelial cells that re-enter
G1-phase from quiescence [30].
In the present study, we explored the requirements for
cell spreading, stress fibers, FAs, and MAPK signaling in
cell cycle progression in cycling cells, as well as the cross-
talk between MAPK, cell spreading and the cytoskeleton.
We have focused on cell cycle progression supported by
fibronectin (FN), as most studies concerning integrin-
mediated cytoskeletal tension and proliferation center on
FN-binding integrins, most importantly integrin a5b1 [27,
28, 31, 32]. To obtain synchronized cycling cells, we have
collected cells from asynchronously growing cultures of
N2A and CHO cells by mitotic shake-off, which yields
high numbers of cells in cytokinesis without the use of
metaphase-blocking agents such as nocodazole, and we
have previously extensively characterized cell cycle regu-
lation in these cells [29, 33, 34]. Although both cell lines
are mitogen- and adhesion-dependent, we also investigated
cell cycle progression in non-transformed mouse GEb1
cells, as the tensional requirements for cell cycle progres-
sion are frequently lost in transformed cells [5].
Materials and methods
Antibodies and other materials
CCD, DMSO, FN, UO126, and TRITC-conjugated phal-
loidin were from Sigma (Steinheim, Germany). BrdU was
from Invitrogen, DAPI was from Boehringer-Mannheim,
and LB was from Calbiochem (San Diego, CA). CCD and
LB were prepared as 1 mg/ml stock solutions in DMSO,
and further diluted in culture medium to the indicated
concentrations. Antibodies used in this study were directed
against BrdU (Bu20a from DAKO, Carpinteria, CA),
Cyclin A (Oncogene), Cyclin B1 (Santa Cruz), Cyclin D1/
D2 (Upstate Biology), FAK (Transduction Laboratories),
p42 MAPK (Upstate Biology), paxillin (Transduction
Laboratories), P(p44/p42) MAPK (Cell Signalling Tech-
nology), P(Y) (4G10; a kind gift of Dr. K. Wilhelmsen),
P(Y397)FAK (Invitrogen), P(Y925)FAK (Biosource),
P(Y31)paxillin and P(Y118)paxillin (Biosource), securin
(Abcam), and vinculin (Sigma). FITC-, TRITC-, CY5-, and
Hrp-conjugated secondary antibodies were purchased from
Jackson ImmunoResearch Laboratories.
Cell culture and synchronization
N2A (Neuro2A) cells were derived from a spontaneous
murine neuroblastoma, CHO cells were isolated from the
ovary of an adult Chinese hamster, and GEb1 cells were
generated by stable expression of the integrin b1-subunit
into epithelial GE11 cells derived from the b1-null mouse
embryo [35]. All cell lines were maintained in DMEM
supplemented with 10% FCS (Gibco) and penicillin/
streptomycin (100 U/ml) at 37C and 5 % CO2. Mitotic
cells were obtained by shaking asynchronously growing
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cell cultures firmly by hand for 1 min at 37C, and col-
lecting the medium as described previously [36]. After
shake-off, mitotic cells were released on coverslips
(Menzel, Germany) or in tissue-culture plates (Corning,
NY) at a density of 1.5 9 104 cells/cm2. Coverslips and
tissue-culture plates were coated with FCS and FN (10 lg/
ml) over night at 37C.
Western blotting
Cells were washed once with ice-cold PBS and subse-
quently lysed on ice in RIPA buffer (20 mM Tris/HCl (pH
7.5), 150 mM NaCl, 1 % Triton X-100, 1 % sodium deso-
xycholate, 0.1 % SDS, 1 mM EDTA, 100 mM NaF, 1 mM
benzamine, 1 mM PMSF, and 1 mM Na3VO4). Collected
lysates were cleared for 2 min at 8,000 9 g and protein
amounts were measured with a Bradford assay using a Bio-
Rad Novapath microplate reader. Equal amounts of protein
were fractionated on 10 or 15 % gels, after which they were
electrophoretically transferred to PVDF membranes (Bo-
ehringer-Mannheim, Indianapolis, IN) according to
standard procedures. The membranes were blocked with
2 % BSA in PBS containing 0.1 % Tween-20 (Sigma),
prior to incubation for 1 h with primary antibodies. After
washing, the membranes were incubated for 1 h with sec-
ondary antibodies, washed again, and immunoreactivity
was detected using ECL reagents (Perkin-Elmer).
Microscopy
Cell morphology in tissue-culture plates was visualized using
a Zeiss microscope (Axiovert 25) at 109 (NA 0.25) and 209
(NA 0.3) magnification. Images were captured on a CCD
camera (Axiocam MRC), using Mr. Grab 1.0 software
(Zeiss). Time-lapse video microscopy was performed on a
Widefield CCD system using a 109 dry lens objective (Carl
Zeiss MicroImaging, and images were captured every
15 min at 37C and 5 % CO2. For immunofluorescence, cells
on coverslips were fixed in 4 % paraformaldehyde (PFA) in
PBS for at least 15 min, after which they were permeabilized
with 0.5 % Triton X-100. For BrdU stainings, the nuclei
were subsequently denatured with 2 N HCl for 30 min at
37C. After washing twice with PBS, cells were blocked in
50 mM glycin in PBS for at least 10 min, and washed twice
with 0.2 % gelatin in PBS (PBG). Subsequently, they were
incubated with primary antibodies for 1 h, washed three
times with PBG, and incubated with secondary antibodies for
1 h. Cells were then washed again three times with PBG, and
once with PBS containing DAPI. Coverslips were mounted
in Mowiol supplemented with DABCO (Calbiochem), and
analyzed on a confocal microscope using 209 (NA 0.7) dry,
409 (NA 1.25), and 639 (NA 1.32) oil objectives (Leica).
Images were acquired with AxioVision software (Carl Zeiss
MicroImaging), and processed using ImageJ and Adobe
Photoshop software. Combined DAPI-phase/contrast images
were captured on a Zeiss AxioObserver Z1 inverted micro-
scope equipped with a cooled CCD-camera (Hamamatsu
ORCA AG) using AxioVision software.
BrdU/EdU labeling and quantification
Synchronized cells were released in fresh medium con-
taining BrdU (10 lM) in 96-well plates at a density of
1 9 104 cells per well, and treated with the inhibitors at the
indicated time-points. The cells were fixed 14 h after
mitosis, and BrdU incorporation was determined using the
Cell Proliferation, Enzyme-linked Immunosorbent Assay
(ELISA) kit (Boehringer-Mannheim), according to the
manufacturer’s instructions. Absorbance was measured on
a Bio-Rad Novapath microplate reader 5 min after sub-
strate addition. In each experiment, cells supplemented
with BrdU were fixed before S-phase (5 h after mitosis) as
a negative control. Independent experiments were per-
formed with six samples for each condition, and each
experiment was repeated at least three times. Incorporation
of BrdU was also analyzed by immunofluorescence, by
incubating cells on coverslips with 10 lM BrdU for the
indicated time-points. Cells were then fixed, and incorpo-
rated BrdU was detected as described above. Alternatively,
cells were incubated on coverslips with 10 lM EdU, and
EdU incorporation was visualized using the Click-iT EdU
imaging kit (Invitrogen) followed by confocal microscopy,
according to the manufacturers’ instructions.
Analysis of cell spreading, bi-nucleation, and nuclear
cyclin D
To determine the cell surface area, synchronized cells were
seeded in tissue-culture plates, treated as indicated, and
fixed with 4 % PFA at appropriate time-points. Phase/
contrast images were acquired as described, and the cell
area of *100 cells per condition was determined using
ImageJ software. To determine the bi-nucleation index,
synchronized cells were seeded on coverslips or tissue-
culture plates and treated as indicated, after which they
were washed and released in fresh medium for 1 h, fixed,
and labeled with DAPI (5 lg/ml). Phase/contrast and DAPI
images were acquired from multiple fields, and in each
independent experiment, bi-nucleation was determined for
300 cells. To quantify nuclear cyclin D, synchronized cells
were plated on coverslips and treated for the indicated
time-points, after which cyclin D1/D2 and nuclei were
stained for confocal microscopy as described above. Ima-
ges were acquired from multiple fields using the same
settings, and cyclin D(?)-nuclei were quantified with
ImageJ from *250 cells per experiment.
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Results
Disruption of the actin cytoskeleton in G1-phase
reverses post-mitotic cell spreading and focal adhesion
assembly
Here we employ the mitotic shake-off method to collect
cells in cytokinesis from asynchronously growing cell
cultures. Released cells reattach to the substratum within
15 min and most of them complete cytokinesis within 1 h
after synchronization, whereafter cell spreading increases
progressively throughout G1-phase (Fig. 1a). Whereas
D-type cyclins are expressed in mitotic cells and
throughout the entire G1-phase, expression of S-phase
promoting cyclin A is induced about 5 h after mitosis, and
the G2/M-phase cyclin B1 becomes detectable from 10 h
after mitosis (Fig. 1b). The population undergoes the next
cytokinesis approximately 16 h after synchronization (data
not shown). The induction of cyclin A expression marks
the onset of S-phase, and progression to S-phase requires
the sustained activity and nuclear translocation of p44/p42
MAPK, as these events are blocked using UO126, an
inhibitor of the MAPK pathway (Fig. 1c, d) [33].
To investigate whether cytoskeletal organization and
cell spreading are required for cell cycle progression in G1-
phase in cycling N2A cells, we used the actin-destabilizing
Fig. 1 Disruption of actin stress fibers in G1-phase causes cell
rounding and FA disassembly. a Stills from a time-lapse movie
showing N2A cells undergoing cytokinesis and post-mitotic cell
spreading. b N2A cells were synchronized by mitotic shake-off and
released in fresh medium. Cells were lysed at the indicated time-
points and the sequential expression of cyclin D1/D2, cyclin A, and
cyclin B1 was determined by Western blotting. c N2A cells were
synchronized by mitotic shake-off and released in the presence of
10 lM BrdU. Progression into S-phase was determined at the
indicated time-points by analyzing BrdU incorporation by immuno-
fluorescence. d Progression from mitosis to S-phase is largely
prevented by inhibition of the MAPK pathway with the inhibitor
UO126 (20 lM). e N2A cells were synchronized by mitotic shake-off
and released in fresh medium. After 3 h, cells were either left
untreated (upper panel), treated with 500 ng/ml CCD (mid panel) or
100 ng/ml LB (lower panel), and photographed at 1 or 3 h thereafter.
Bar 10 lm. f Cell area was determined at the indicated time-points
from phase-contrast images using ImageJ, and expressed relative to
the cell area of mitotic cells. AU arbitrary units. g N2A cells were
synchronized by mitotic shake-off and treated with 500 ng/ml CCD or
100 ng/ml LB 3 h thereafter. Cells were fixed after 3 h of incubation
and the nuclei (blue), F-actin (red), and vinculin (green) were
visualized with confocal microscopy. Bar 10 lm
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drugs cytochalasin D (CCD) and latrunculin B (LB). Both
drugs favor depolymerization of actin filaments but they
act by distinct mechanisms; whereas CCD caps the grow-
ing ends of actin polymers, LB sequesters actin monomers.
Mitotic cells were allowed to re-adhere and spread on FN-
coated dishes in fresh medium with serum, after which they
were treated with 500 ng/ml CCD or 100 ng/ml LB at
progressive time-points in G1-phase. Post-mitotic cell
spreading was quantified by measuring the apparent surface
area from phase-contrast images. Cell spreading of
untreated cells increased from mitosis into G1, and treat-
ment of spread cells in G1-phase (from 3 h after mitosis)
with either CCD or LB for 1 h (M ? 3_1) or 3 h
(M ? 3_3) induced cell rounding (Fig. 1e, f). We next
Fig. 2 Disruption of actin stress fibers in G1-phase inhibits integrin
signaling and growth factor signaling. a N2A cells were synchronized
by mitotic shake-off, released in fresh medium, and 3 h after
synchronization they were either left untreated (top row), treated with
500 ng/ml CCD (middle row), or treated with 100 ng/ml LB (bottom
row). Cells were fixed 3 h later and the nuclei (blue), F-actin (red),
and phosphorylation of FAK and paxillin at the indicated residues
(green) were visualized with confocal microscopy. Bar 10 lm.
b N2A cells were synchronized by mitotic shake-off and 3 h later
treated as described. Cells were lysed 2, 3, 4, and 5 h thereafter and
autophosphorylation of (Y397)FAK, phosphorylation of (Y118)pax-
illin, and phosphorylation of p44/p42 MAPK, as well as total levels of
FAK, paxillin, and p42 MAPK were investigated by Western blotting
MAPK permits cell cycle progression without cell spreading 297
123
analyzed cytoskeletal organization and FA assembly in G1-
phase, using the filamentous actin (F-actin)-binding com-
pound phalloidin and an antibody against the FA marker
vinculin, which is involved in linking integrins to the actin
cytoskeleton. Actin stress fibers associated with FAs were
observed in spread cells in G1-phase, and treatment with
either drug induced FA loss and dissolution of actin stress
fibers, whereas some F-actin was retained in membrane
structures left behind after cell rounding (Fig. 1g). Thus,
treatment with CCD or LB in G1-phase cells disrupts the
normal organization of the actin cytoskeleton, and induces
cell rounding and FA disassembly.
Disruption of the actin cytoskeleton in G1-phase
inhibits integrin signaling and growth factor signaling
Integrin-mediated re-adhesion and cell spreading after
mitosis triggers the auto-phosphorylation of one of the
major kinases in FAs, focal adhesion kinase (FAK), on
Y397 [29, 37]. Autophosphorylation of FAK triggers the
recruitment of Src, which subsequently phosphorylates
FAK on Y925. In turn, FAK interacts with the signal
transduction adapter protein paxillin, and induces its
phosphorylation at Y118 and Y31. To determine whether
cytoskeletal disruption and cell rounding induced by CCD
or LB in G1-phase cells affects integrin signaling, we
treated G1-phase cells 3 h after mitosis with the actin
inhibitors, and investigated the phosphorylation of paxillin
and FAK by immunofluorescence and Western blotting.
Whereas paxillin phosphorylation on Y118 and Y31 and
FAK phosphorylation on Y397 and Y925 were clearly
visible in FAs in untreated cells, reduced or no phosphor-
ylation on these residues was observed in the CCD- or LB-
treated cells (Figs. 2a, b), indicating that disruption of the
actin cytoskeleton in G1-phase inhibits integrin-mediated
signaling events. Because integrin-mediated cell spreading
and organization of the actin cytoskeleton support growth
factor signaling, we next investigated whether disruption of
actin stress fibers in G1-phase cells also impedes growth
factor-induced MAPK phosphorylation. MAPK phosphor-
ylation in untreated cells was detected throughout G1, but
was considerably reduced upon treatment with CCD or LB
Fig. 3 Disruption of actin stress fibers in G1-phase does not inhibit
S-phase entry in continuously cycling N2A cells. a N2A cells were
synchronized by mitotic shake-off and 3 h later treated as described.
Cells were lysed 2, 3, 4, and 5 h thereafter and expression of cyclin D
and cyclin A was investigated by Western blotting (p42 MAPK =
loading control). b N2A cells were synchronized by shake-off,
released in fresh medium containing 10 lM BrdU, and CCD or LB
were added at the indicated time-points. After 14 h, cells were fixed
and BrdU incorporation was determined with an ELISA. Incorporation
in untreated cells was set to 100 %. The graph represents the
averages ± SEM from three independent experiments. c Mitotic N2A
cells were released on coverslips in fresh medium containing 10 lM
BrdU, and CCD or LB were added at 0, 2, 4, or 6 h after mitosis.
Incorporation of BrdU at the indicated time-points was determined by
immunofluorescence
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(Fig. 2b), confirming that growth factor signaling in G1
depends on intact actin filaments. Taken together, these
results indicate that disruption of the actin cytoskeleton and
cell spreading in G1-phase cells attenuates both integrin
signaling and growth factor signaling.
G1/S-phase progression in cycling N2A and CHO cells
is not inhibited by disruption of the actin cytoskeleton
and cell spreading
We next examined whether cell cycle progression into
S-phase was affected by the disruption of actin filaments.
First, we treated cells with the drugs starting at 3 h after
mitosis until well into S-phase (8 h post-mitosis), and then
analyzed the expression of cyclin D by Western blotting.
Consistent with previous observations, a progressive
decline in cyclin D levels was observed in CCD- or LB-
treated cells, but expression was not abolished completely
(Fig. 3a). Moreover, cytoskeletal disruption did also not
impair the induction of cyclin A expression (Fig. 3a). We
then analyzed whether these cells progressed through
S-phase by releasing synchronized cells in medium con-
taining the thymidine analogue BrdU, and measuring BrdU
incorporation 14 h after mitosis using an ELISA. To assess
whether there is a specific time-frame in G1 that requires
cytoskeletal integrity, CCD or LB were added at 0, 2, 4, or
6 h after synchronization. Interestingly, drug addition at
neither time-point decreased BrdU incorporation as com-
pared to untreated cells, indicating that also in the presence
of the drugs, the entire cell population had entered and
completed S-phase (Fig. 3b). In contrast, disruption of the
actin cytoskeleton did prevent S-phase entry in quiescent
cells that were serum-stimulated to re-enter the cell cycle
(Suppl. Fig. 1), as has been documented extensively in a
variety of cell types [7, 9, 10, 12, 13, 15]. We then inves-
tigated whether the drugs caused a delay or acceleration in
the rate of progression from mitosis to S-phase, by ana-
lyzing BrdU incorporation at several time-points for up to
10 h after mitosis. BrdU incorporation was identical in all
conditions, suggesting that disruption of the cytoskeleton
does not affect the rate of G1-phase progression (Fig. 3c).
To exclude that the observed phenomenon is restricted to
N2A cells, we next analyzed the same events in CHO cells
isolated by mitotic shake-off. Similar to in N2A cells,
incubation of spread post-mitotic CHO cells with CCD or
LB induced cell rounding and disruption of stress fibers and
FAs (data not shown). Correspondingly, FAK autophos-
phorylation and MAPK phosphorylation were also reduced
in CHO cells (Suppl. Fig. 2A). However, as in N2A, pro-
gression to S-phase was not prevented, as indicated by
expression levels of cyclin A and BrdU incorporation, and
no actin cytoskeleton-dependent time-window for G1/S-
phase progression was detected (Suppl. Fig. 2B). Together,
these results suggest that disruption of the actin cytoskele-
ton during G1-phase does not inhibit progression from
mitosis to S-phase in cycling N2A and CHO cells, despite
decreased integrin signaling and growth factor-stimulated
MAPK phosphorylation.
G1/S-phase progression in the absence of cell spreading
or stress fibers depends on MAPK signaling
The previous sections have shown that in the absence of
cell spreading, actin stress fibers or detectable FAs, cycling
N2A and CHO cells can progress from mitosis to S-phase,
despite strongly reduced MAPK activity. Because normal
progression from mitosis to S-phase requires sustained
MAPK activity throughout G1-phase (Fig. 1d) [33], we
next explored the cross-talk between MAPK signaling and
cytoskeletal organization, and the requirement for MAPK
activity in cytoskeleton-disrupted cells. We therefore syn-
chronized N2A cells by mitotic shake-off and released
them in medium containing 500 ng/ml CCD, 100 ng/ml
LB, or 20 lM UO126. Western blotting for phosphorylated
p44/p42 MAPK levels revealed that UO126 inhibited
MAPK activity much more rigorously than CCD and LB,
as phospho-MAPK was virtually absent after prolonged
incubation with UO126, even on overexposed blots
(Fig. 4a). In contrast, P(Y397)FAK was strongly inhibited
by CCD or LB but not by UO126, indicating that integrin-
dependent events do not require MAPK activity (Fig. 4a)
Consistent with this notion, cell spreading, stress fiber
formation, or FA assembly (visualized using an antibody
against phosphotyrosines) were not affected by treatment
with UO126 (Fig. 4b). We then incubated cells in the
presence of CCD or LB together with UO126, and deter-
mined whether these cells progressed into S-phase by
measuring BrdU incorporation as described above.
Intriguingly, the addition of UO126 strongly prevented
BrdU incorporation, indicating that cell cycle progression
in cytoskeleton-disrupted cells critically depends on
MAPK activity (Fig. 4c). Taken together, these data indi-
cate that MAPK activity is not required for cell spreading,
cytoskeletal organization, and integrin signaling. However,
MAPK is crucial for cell cycle progression, both in
untreated and cytoskeleton-disrupted cells.
Cycling N2A cells progress through G2- and M-phase
in the absence of cell spreading, actin stress fibers,
or focal adhesions
We next investigated whether cell cycle progression pro-
ceeded after S-phase through G2 and the next M-phase. For
this purpose, synchronized cells were treated with the actin
inhibitors at several time-points in G1 as described above,
and the expression of the G2/M markers cyclin B1, which
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together with cdk1 promotes entry into mitosis, and securin,
an essential modulator of metaphase-anaphase transition,
was determined by Western blotting. Intriguingly, both
cyclin B1 and securin were detectable from 10 h after
mitosis in all conditions, suggesting that cells with dis-
rupted cytoskeletons progress normally though G2-phase
and complete their whole cycle (Fig. 5a and data not
shown). We then incubated synchronized cells for the
length of more than an entire cell cycle with the actin
inhibitors. Suppression of actin polymerization during
mitosis leads to cleavage failure, creating bi-nucleated cells.
We therefore used bi-nucleation as a parameter for cell
cycle completion in the presence of CCD or LB. After 20 h
of incubation, cells were still rounded, indicating that the
inhibitors were still functional (data not shown). The drugs
were then washed out, and the cells were allowed to recover
for 1 h in fresh medium, in which cell spreading was
resumed (Fig. 5b). Cell spreading was accompanied by de
novo re-organization of the actin cytoskeleton into stress
fibers, as well as FA assembly and integrin signaling, as
judged by staining for phosphorylated (Y118)paxillin
(Fig. 6). In line with the expression of cyclin B1 and sec-
urin, the vast majority of the CCD- and LB-treated N2A
cells was bi-nucleated, confirming that they had indeed
progressed through G2- and M-phase (Fig. 5b). Moreover,
immunofluorescence analysis revealed that all bi-nucleated
cells had incorporated BrdU (Suppl. Fig. 3). This is in line
with the results obtained with the ELISAs, and reaffirms
that the bi-nucleated cells have gone through an entire
cycle. Intriguingly, nuclear localization of cyclin D was
detected in bi-nucleated cells (Fig. 6). Nuclear import of
cyclin D occurs in growth-committed cells in G1-phase and
is necessary for passage of the restriction point, whereas its
subsequent export and degradation in the cytoplasm is
required during S-phase [38]. During the ongoing cell cycle,
nuclear cyclin D is detectable starting 2 h after mitosis until
the onset of S-phase (*6 h after mitosis), whereafter
nuclear cyclin D levels decrease (Suppl. Fig. 4).
Fig. 4 Progression through G1-phase in the absence of cell spreading
and stress fibers depends on MAPK signaling. a N2A cells were
synchronized by shake-off and released in fresh medium supple-
mented with 500 ng/ml CCD, 100 ng/ml LB, or 20 lM UO126. Cells
were lysed at the indicated time-points after synchronization, and
phosphorylation of p44/p42 MAPK and (Y397)FAK were investi-
gated by Western blotting (p42 MAPK = loading control). b Top
phase-contrast images of N2A cells that were incubated for up to 5 h
after mitosis in the absence (left) or the presence of 20 lM UO126
(right). Bar 10 lm. Bottom; Confocal images showing F-actin (red),
FAs (visualized with an antibody against phosphotyrosines, green)
and nuclei (blue) in N2A cells that were incubated for up to 5 h after
mitosis in the absence (left) or the presence of 20 lM UO126 (right).
Bar 10 lm. c Mitotic N2A cells were released on coverslips in fresh
medium containing either 20 lM UO126 alone, 20 lM UO126 and
CCD (500 ng/ml), or 20 lM UO126 and LB (100 ng/ml). BrdU
incorporation was then determined 14 h later by immunofluorescence.
The graph represents the averages from *300 cells ± SEM from
three independent experiments
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Quantification of cyclin D-positive nuclei revealed that
cyclin D accumulation in the nucleus of CCD- or LB-
treated cells was similar to that in untreated cells (Fig. 7),
suggesting that these cells not only completed an entire
cycle, but even committed to a new one in the presence of
the drugs. However, during prolonged treatment with the
inhibitors over several days, the multi-nucleated population
underwent massive apoptosis, possibly due to genomic
instability (data not shown). Summarizing, the data
presented here show that N2A and CHO cells can progress
through the continuous cell cycle in the absence of exten-
sive cell spreading, stress fibers, or FAs.
Cycling GEb1 cells do not require cell spreading, actin
stress fibers, or focal adhesions
In the previous sections, we have shown that FN-supported
cell cycle progression in cycling N2A and CHO cells does
Fig. 5 Cycling N2A cells progress through G2- and M-phase in the
absence of cell spreading or cytoskeletal integrity. a N2A cells were
collected by shake-off and treated with CCD or LB at 2 or 4 h after
synchronization. Cells were lysed at 8, 10, or 14 h after synchroni-
zation, and expression of cyclin B1 and securin were detected by
Western blotting. b N2A cells were collected by shake-off and treated
with CCD or LB at the indicated time-points after synchronization.
The drugs were washed away after 20 h, after which the cells were
released in fresh medium for 1 h. They were then fixed, stained with
DAPI, and the percentage of mono- and bi-nucleated cells was
determined from *300 cells per experiment. The graph represents
the averages ± SEM from three independent experiments
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not depend on an intact cytoskeleton or cell spreading,
which is in apparent contrast to studies using non-trans-
formed capillary endothelial cells and fibroblasts, in which
cell cycle re-entry from quiescence is inhibited upon dis-
ruption of the actin cytoskeleton [7–14]. The tensional
requirements for cell cycle progression may differ between
non-transformed and transformed cells. We therefore ana-
lyzed FN-supported cell cycle progression under the same
conditions in GEb1 cells, which predominantly express
FN-binding integrin a5b1, and do not display typical
hallmarks of oncogenic transformation (they do not grow
without growth factors or in soft agar, and do not form
tumors in mice unless transformed with oncogenic Ras)
[35, 39, 40]. Mitotic GEb1 cells were isolated by shake-off
and released on FN, after which they were treated with
CCD (250 ng/ml) or LB (100 ng/ml) at appropriate time-
points in G1. Cytoskeletal organization, FA assembly, and
integrin-induced signaling events were visualized using
phalloidin and an antibody against tyrosine-phosphorylated
proteins. Post-mitotic GEb1 cells resumed cell spreading
and re-gained stress fibers and FAs within 2 h, and cell
spreading increased progressively thereafter (Fig. 8a).
Treatment with either drug in G1-phase abolished actin
stress fibers, cell spreading, FA assembly, and tyrosine
phosphorylations within 1 h (Fig. 8a). We next investi-
gated cell cycle progression in the presence of the
inhibitors, by determining the bi-nucleation index as
described above. Drugs were washed away 20 h after
Fig. 6 Cell spreading and actin stress fibers are dispensable for
nuclear translocation of cyclin D1/D2 in cycling N2A cells. N2A cells
were synchronized by shake-off and treated with CCD or LB at the
indicated time-points after synchronization. After 20 h, the drugs
were washed away and the cells were fixed 1 h later, after which they
were processed for microscopy using phalloidin-TRITC and DAPI, as
well as antibodies against cyclin D1/D2 and P(Y118)paxillin. Pictures
were obtained on a confocal microscope. Top nuclei (blue), F-actin
(red), P(Y118)paxillin (green). Bottom cyclin D1/D2. Bar 10 lm
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mitosis, and cells were allowed to recover in fresh medium.
A complete recovery of actin stress fibers, cell spreading,
and FA assembly was observed 1.5 h after drug wash-out,
and the vast majority of the cells appeared to have two
nuclei (Fig. 8b). Indeed, bi-nucleation indices clearly show
that disruption of the actin cytoskeleton at neither time-
point in G1-phase induced a cell cycle arrest (Fig. 8c).
Taken together, these data show that similar to in N2A and
CHO cells, cell cycle progression in cycling GEb1 cells
does not depend on actin stress fibers, FAs, or extensive
cell spreading.
Discussion
In this study, we investigated the requirements for FA
assembly, cytoskeletal integrity, cell spreading, and MAPK
activity in FN-supported progression through the ongoing
cell cycle. Mitotic N2A and CHO cells were collected by
shake-off and released on FN-coated dishes, after which
post-mitotic actin stress fiber formation was abolished with
pharmacological agents at progressive time-points during
G1-phase. Cell spreading, FA assembly, and integrin sig-
naling were disrupted by this treatment. Furthermore,
Fig. 7 Disruption of cytoskeletal integrity and cell spreading does
not prevent entry into a new cell cycle. N2A cells were collected by
shake-off and treated with CCD or LB at the indicated time-points
after synchronization. After 20 h, the cells were fixed and cyclin D1/
D2 (green) and the nuclei (blue) were visualized with confocal
microscopy. The percentage of cyclin D(?) cells was quantified using
ImageJ from confocal images acquired with the same settings. For
each condition, *250 cells were analyzed and the graph represents
the averages ± SEM from three independent experiments. Bar 50 lm
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growth factor-induced p44/p42 MAPK phosphorylation
was also considerably decreased, confirming the well-
established link between integrin-mediated cytoskeletal
organization and growth factor signaling [41–43]. Conse-
quently, we observed a decline in cyclin D levels, in line
with a number of reports showing that optimal cyclin D
expression is jointly regulated by growth factors and inte-
grin-mediated cell spreading and cytoskeletal organization
[5, 12–15, 26–28]. However, the residual cyclin D levels
were apparently sufficient to support G1-phase progression
into S-phase, since expression of cyclin A was not
prevented, and virtually all cells committed to DNA syn-
thesis. It thus seems that for cells that enter G1-phase from
mitosis, G1-phase progression does not depend on cyto-
skeletal tension. In fact, the vast majority of the cells
completed the entire cycle in the absence of detectable
actin filaments, giving rise to a population of giant bi-
nucleated cells due to absence of the actin contractile ring
that separates the daughter cells during cytokinesis.
The results presented here complement our previous
study, and suggest that cycling cells do not require an intact
cytoskeleton or cell spreading, as long as expression of
Fig. 8 Cell cycle progression in GEb1 cells does not require cell
spreading, actin stress fibers, or FAs. a GEb1 cells were synchronized
by mitotic shake-off, released in fresh medium on FN-coated
coverslips, and then fixed in G1-phase at the indicated time-points.
Alternatively, they were treated with CCD (250 ng/ml) or LB
(100 ng/ml) 3 h after mitosis, and fixed 1 h later. The nuclei (blue),
F-actin (red), and FAs (stained with an antibody against phosphoty-
rosines; green) were visualized with confocal microscopy. Bar
10 lm. b (top) GEb1 cells were synchronized by shake-off and
treated with CCD or LB at the indicated time-points after synchro-
nization. After 20 h, the drugs were washed away and the cells were
released in fresh medium. They were fixed 1 h later, and nuclei
(blue), F-actin (red), and P(Y118)paxillin (green) were visualized
with confocal microscopy. Bar 10 lm. Bottom GEb1 cells were
treated as in b, fixed, and stained with DAPI. The percentage of
mono- and bi-nucleated cells was determined from *300 cells per
experiment. The graph represents the averages ± SEM from three
independent experiments
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cyclin D is maintained. Furthermore, we now show that
nuclear translocation of cyclin D during G1-phase of con-
tinuously cycling cells occurs independently of cell
spreading/cytoskeletal organization. Thus, cyclin D
expression (but not its nuclear translocation) depends on
cell spreading and the cytoskeleton, which is in line with
observations in cells that were growth factor-stimulated to
re-enter G1-phase from G0 [44, 45]. Nuclear translocation
of cyclin D is a key event in G1-phase that is required for
phosphorylation of the retinoblastoma protein and passage
of the restriction point [37]. However, export of cyclin D
out of the nucleus and its subsequent cytoplasmic degra-
dation are important for normal passage through S-phase
[46, 47]. It is thus paramount that nuclear trafficking of
cyclin D is tightly regulated. Indeed, whereas overexpres-
sion of cyclin D is observed in many tumor cells, it is by
itself not sufficient for oncogenic transformation, and
accumulating evidence suggests that transformation is dri-
ven by nuclear retention of cyclin D [38]. Strategies that
target the nuclear trafficking of D-type cyclins rather than
merely their expression may therefore prove to be effective
in the treatment of cancer. Because the expression of cyclin
D is tightly linked to MAPK activity, and sustained MAPK
activity throughout G1-phase until the restriction point is
important for integrin-regulated cell cycle progression, an
interesting question that arises from our data is whether the
observed cell cycle progression in cells with disorganized
cytoskeletons has become independent of MAPK. To
delineate the cross-talk between MAPK, the cytoskeleton,
and cell spreading in cycling cells, we inhibited the MAPK
pathway using the inhibitor UO126. UO126 robustly
inhibited progression to S-phase, but cell morphology and
cytoskeletal organization, as well as FA assembly and
integrin-stimulated autophosphorylation of FAK were not
affected. Thus, although cell spreading and the cytoskeleton
potentiate MAPK activation, the MAPK pathway seems not
reciprocally involved in integrin signaling and integrin-
mediated cell spreading and cytoskeletal organization.
Intriguingly, cell cycle progression in cytoskeleton-dis-
rupted cells was also inhibited by UO126. These data thus
identify the MAPK pathway as the mechanism that drives
proliferation in the absence of cell spreading and cyto-
skeletal tension, and suggest that cell cycle progression can
be uncoupled from tensional and morphological require-
ments by MAPK activation. It has been suggested that the
tension-requirement for cell cycle progression differs
between transformed and non-transformed cells, based on
the observation that re-entry into G1-phase from quiescence
is prevented by cytoskeletal disruption in non-transformed
primary capillary endothelial cells and NIH3T3 fibroblasts
overexpressing integrin a5b1 [5]. Indeed, transformation
induces cell rounding and a loss of actin stress fibers, and a
number of early reports have shown that actin-destabilizing
agents do not affect proliferation in cycling transformed
cells [48–50]. We therefore aimed to investigate whether
integrin a5b1-supported cell cycle progression depends on
cytoskeletal organization and cell spreading in cycling non-
transformed cells. First, we generated NIH3T3 cells that
stably overexpress a5b1, however shake-off experiments
with this cell line did not yield sufficient numbers of mitotic
cells (data not shown). We then chose GEb1 cells as a
model system, because they (1) predominantly express
integrin a5b1 whereas the expression of other integrins is
negligible, (2) display a well-spread, fibroblast-like shape
with extensive actin stress fibers and FAs, (3) do not grow
without growth factors or in soft agar, and (4) are impor-
tantly not tumorigenic in mice unless transformed with
oncogenic Ras [40]. We thus consider GEb1 cells to be a
non-transformed cell line, at least with respect to growth-
control mechanisms and cell cycle requirements. Intrigu-
ingly, cell cycle progression in cycling GEb1 cells was not
impaired by disruption of cytoskeletal integrity, cell
spreading, and FA assembly in G1-phase, similar to what
we have observed in CHO and N2A cells. We therefore
conclude that cycling mammalian cells, transformed and
non-transformed alike, can proliferate in the absence of
cytoskeletal tension or cell spreading, provided that there is
MAPK signaling to sustain threshold levels of cyclin D.
Nevertheless, it is likely that cell cycle regulation in dif-
ferent cell types involves different regulatory mechanisms.
For example, regulation of cell proliferation by cell shape
and cytoskeletal tension has been well documented for
fibroblasts and endothelial cells, which adopt a more
‘‘tensile’’ morphology than epithelial cells. Indeed, E-cad-
herin signals rather than cell-matrix interactions can drive
cyclin D expression in epithelial cells [51]. Furthermore,
whereas stress fibers are not commonly observed in cells in
vivo, specialized cell types as wound fibroblasts and myo-
fibroblasts develop them under conditions of great
mechanical stress which require both proliferation and
contraction, such as wound healing [52]. Probably, these
cell types retain the tensional requirement for cell cycle
entry from quiescence in vitro.
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